Immune Checkpoint Inhibitors (ICIs) in Non-Small Cell Lung Cancer (NSCLC).

Yoneda, Kazue; Imanishi, Naoko; Ichiki, Yoshinobu; Tanaka, Fumihiro

Yoneda, Kazue; Imanishi, Naoko; Ichiki, Yoshinobu; Tanaka, Fumihiro.

Afiliação

Yoneda K; Second Department of Surgery (Chest Surgery), School of Medicine, University of Occupational and Environmental Health, Japan.
Imanishi N; Second Department of Surgery (Chest Surgery), School of Medicine, University of Occupational and Environmental Health, Japan.
Ichiki Y; Second Department of Surgery (Chest Surgery), School of Medicine, University of Occupational and Environmental Health, Japan.
Tanaka F; Second Department of Surgery (Chest Surgery), School of Medicine, University of Occupational and Environmental Health, Japan.

J UOEH ; 40(2): 173-189, 2018.

Article em En | MEDLINE | ID: mdl-29925736

Assuntos

Carcinoma Pulmonar de Células não Pequenas/terapia; Imunoterapia; Neoplasias Pulmonares/terapia; Antígeno B7-H1/imunologia; Carcinoma Pulmonar de Células não Pequenas/imunologia; Humanos; Neoplasias Pulmonares/imunologia; Terapia de Alvo Molecular; Receptor de Morte Celular Programada 1/imunologia

Palavras-chave

PD-1; PD-L1; cancer immunity; immune checkpoint; lung cancer

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Imunoterapia / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google